SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
September 28, 2001
OMNICARE, INC.
(Exact Name of registrant as specified in its charter)
Delaware 1-8269 31-1001351
(State or other (Commission (I.R.S. Employer
jurisdiction File Number) Identification No.)
of Incorporation)
100 East RiverCenter Blvd.
Suite 1600
Covington, KY 41011
(Address of principal (Zip Code)
executive offices)
(859) 392-3300
(Registrant's telephone number, including area code)
Item 5. Other Events
The Registrant reports the implementation of the second phase of
a productivity and consolidation initiative that is intended to streamline
operations, increase efficiency and enhance the Registrant's position as a high
quality, cost-effective provider of pharmaceutical services. The Registrant's
press release is attached as an exhibit to this report and incorporated herein
by reference.
Item 7. Financial Statements and Exhibits
EXHIBITS
99(a) Registrant's press release dated September 28, 2001.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
OMNICARE, INC.
(Registrant)
By David W. Froesel, Jr.
/s/ David W. Froesel, Jr.
----------------------------------
Title: Senior Vice President and
Chief Financial Officer
Dated: September 28, 2001
2
EXHIBITS
Exhibit Description
------- -----------
99(a) Registrant's press release dated September 28, 2001